Radiologic presentation of chronic granulomatous prostatitis mimicking locally advanced prostate adenocarcinoma  by Lee, Su-Min et al.
ww.sciencedirect.com
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 7 8e8 2Available online at wScienceDirect
journal homepage: ht tp: / /Elsevier .com/locate/radcrCase Report
Radiologic presentation of chronic granulomatous prostatitis
mimicking locally advanced prostate adenocarcinomaSu-Min Lee a,*, Jay Joshi b, Konrad Wolfe c, Peter Acher a, Sidath H. Liyanage b
a Department of Urology, Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex, SS0 0RY, UK
b Department of Radiology, Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex, SS0 0RY, UK
c Department of Pathology, Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex, SS0 0RY, UKa r t i c l e i n f o
Article history:
Received 26 December 2015
Accepted 8 February 2016
Available online 16 March 2016
Keywords:
Granulomatous prostatitis
Prostate
MRICompeting Interests: The authors have dec
* Corresponding author.
E-mail address: sumin.lee@southend.nhs
http://dx.doi.org/10.1016/j.radcr.2016.02.009
1930-0433/Copyright © 2016, the Authors. Pu
an open access article under the CC BY-NC-a b s t r a c t
We present a case of nonspecific granulomatous prostatitis (GP), a clinical mimic of
prostate adenocarcinoma. A 54-year-old man presented with lower urinary tract symp-
toms and raised prostate-specific antigen. Magnetic resonance imaging showed features
consistent with prostate cancer, including low T2-signal intensity in the peripheral and
transition zones with signs of extracapsular extension. Diffusion-weighted imaging
showed high-signal intensity, with low apparent diffusion coefficient values, whereas
dynamic contrast enhancement demonstrated a type 3 washout curve, similar to that
found in prostate cancer. Transperineal sector-guided prostate biopsy confirmed nonspe-
cific GP, and the patient was treated conservatively. We discuss and compare nonspecific,
chronic GP as a radiologic mimic of prostate adenocarcinoma patient.
Copyright © 2016, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 54-year-old man with symptoms of bladder outflow
obstruction managed with an alpha blocker, tamsulosin, for
2 months and a 5-alpha reductase inhibitor, finasteride, for
1 month presented to urology clinic with rising prostate-
specific antigen (PSA) that was 8.0 ng/mL on referral. He
had suffered a coliform urinary tract infection 2 months
previously that was managed successfully with antibiotics.
Digital rectal examination revealed asymmetric prostate
enlargement with a prominent, firm, right prostate
lobe. The primary differential diagnosis was prostate
adenocarcinoma.lared that no competing i
.uk (S.-M. Lee).
blished by Elsevier Inc. u
ND license (http://creativMultiparametric magnetic resonance imaging (mpMRI)
was carried out using a 1.5 T system (Signa Excite, GE
Healthcare, Little Chalfont, UK) and 8-channel phased array
body coil. The MRI protocol included T2-weighted images (T2)
in 3 planes, diffusion-weighted imaging (DWI), and dynamic
contrast enhanced (DCE) images in the axial plane.
Axial T2 showed homogenous low signal intensity (SI)
involving both the peripheral zone (PZ) and transition zone
(TZ) and diffusely abutting the capsule (Fig. 1). In addition,
evaluation of the right posterolateral PZ at the midgland level
showed focal obliteration of the capsular signal and infiltra-
tion of the periprostatic fat with thickening of the ipsilateral
levator ani (Fig. 2). This gave a Prostate Imaging Reporting andnterests exist.
nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1 e Coronal T2WI and corresponding axial T2WI DWI (b-value 1,400) and ADC maps at the levels of the prostatic base
(A), midgland (B), and apex (C), demonstrating diffuse low T2 SI in the PZ and TZ and multifocal areas of high SI on the DWI
and low SI on the ADC maps. This results in a PI-RADS v2 score of 5 for both T2WI and DWI [1].
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scoring is summarized in Table 1.
High 1400 b-value DWI revealed high SI throughout the PZ
andTZwithmultifocal areas ofparticularlyhyperintenseSI and
corresponding reduced apparent diffusion coefficient (ADC)
values, ranging from 584 to 635  106 mm2/sec (Fig. 3). This
resulted in a PI-RADS v2 score for DWI of 5 [1]. DCE color-coded
ktrans images (Fig. 4) showed a type 3 washout curve and asym-
metric focal enhancement, scored as “positive” on PI-RADS v2.
As magnetic resonance spectroscopic imaging was not
performed, the overall PI-RADS v2 score for the probability ofFig. 2 e T2WI coronal (A) and axial (B) images showing focal defe
arrows). Abnormal T2 SI (asterisk) extends into the periprostati
(arrowheads) in the Diffusion Weighted Image (C) and Apparen
muscle is thickened and of abnormal SI.there being a clinically significant cancer was 5, that is, very
high. Thus, a convincing radiologic diagnosis of prostate
cancer was made based on the MR images, and the patient
was given a provisional stage of T3a N0 disease.
A 42-core, systematic, sector-guided transperineal pros-
tate biopsy, with additional cognitive targeting of the suspi-
cious lesions was performed, as previously described [2,3].
Histologic analysis reported diffuse, nonspecific granuloma-
tous prostatitis (GP). The patientwasmanaged conservatively
and discharged from urological care. His lower urinary tract
symptoms were well managed on medical therapy.ct in the right posterolateral PZ at the midgland level (white
c fat and demonstrates restricted water diffusion
t Diffusion Coefficient map (D). The adjacent levator ani
Table 1 e PI-RADS v2 scoring.
PZ
DWI score (dominant
sequence)
DCE score (secondary
sequence)
T2WI
score
Overall PI-RADS
score
Interpretation
1 Any Any 1 Significant disease highly unlikely to be present
2 Any Any 2 Significant disease unlikely to be present
3  Any 3 Result equivocal
3 þ Any 4 Significant disease is likely to be present
4 Any Any 4 Significant disease is likely to be present
5 Any Any 5 Significant disease is highly likely to be present
TZ
T2WI score (dominant
sequence)
DWI score (secondary sequence) DCE score Overall PI-RADS
score
Interpretation
1 Any Any 1 Significant disease highly unlikely to be present
2 Any Any 2 Significant disease unlikely to be present
3 4 Any 3 Result equivocal
3 5 Any 4 Significant disease is likely to be present
4 Any Any 4 Significant disease is likely to be present
5 Any Any 5 Significant disease is highly likely to be present
Table adapted from “PI-RADS Prostate ImagingdReporting and Data System: 2015, version 2” [1]
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GP is a heterogeneous condition that describes a granuloma-
tous, inflammatory condition of the prostate. This may be
idiopathic, that is, nonspecific, or secondary to causes
including specific infections, bacillus Calmette-Guerin (BCG)
therapy, surgery, and more rarely, systemic causes [4]. It has
an estimated incidence of 3.3% in inflammatory lesions and
commonly affects men in their sixth to eighth decades [4].
A popular theory is that nonspecific GP is caused by
blockage of the prostatic ducts leading to stasis of secretions
and epithelial disruption. Blockage may be secondary toFig. 3 e ADC map showing the ADC values (10¡6 mm2/sec)
for 2 regions of interest placed in areas of very low SI on
the ADC map (circle 1dADC value 584 and circle 2dADC
value 635) indicating marked restricted water diffusion.bacterial products, refluxed urine, or from benign prostatic
hyperplasia [4]. Cellular debris and prostatic secretions leak
into the stroma, leading to a localized inflammatory response
[5]. Infectious GP is most commonly caused by bacteria
including tuberculosis and BCG therapy for bladder transi-
tional cell carcinoma or fungi such as blastomycosis or cryp-
tococcosis [5].
This case of nonspecific GP is an example of clinical and
radiologic mimicking of prostate adenocarcinoma. Clinically,
patients may present with lower urinary tract symptoms
including hematuria, urgency, or urinary frequency. The
prostate may feel firm or have a hard, fixed nodule on digital
rectal examination [4]. Serum PSA levels vary considerably but
are raised in a majority of cases.
Radiologically, GP demonstrates tumor-like morphology,
with either nodular or diffuse hypoechogenic lesions on ul-
trasound [6]. The MRI features of BCG-induced GP have
been reported to be nonspecific. Naik and Carey [6], who
investigated the transrectal ultrasound and MRI (T2- and
T1-weighted precontrast and postcontrast) imaging appear-
ances of BCG-induced GP, concluded that there is no pattern of
clinical, biochemical, ultrasound, or MRI findings which allow
a specific diagnosis of BCG-induced GP to be established or
differentiated from prostate cancer. MRI case series for
nonspecific GP are limited, with only 2 cases reported by
Bour et al [7].
On T2-weighted MRI, GP lesions appear as hypointense SI
regions similar to prostate cancer lesions which commonly
manifest as round or ill-defined, low SI areas within the PZ
[8e10]. Tumors within the TZ are challenging to detect, since
the SI of normal TZ and cancer overlap; tumor is often
demonstrated as a homogeneous signal mass with blurred
margins, the so-called “erased charcoal sign” [8]. High-grade
tumors often have reduced SI, as compared with low-grade
cancers.
GP and cancer lesions share high SI on DWI at high b-
values and low SI on ADC maps [1,8]. ADC values allow
Fig. 4 e DCE color-coded ktrans image (A) showing asymmetric enhancement (“positive” on PI-RADS v2; 1). Region of interest
demonstrates a type 3 (washout) curve (B).
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late with Gleason scoring [10]. GP demonstrates low ADC
values reaching those of the highest Gleason score carci-
nomas (Fig. 3) [9,10].
Limited studies have investigated the appearances of GP on
DCE imaging [7,11]. Bour et al [7] showed only moderate
enhancement in cases of non-necrotic granulomatous foci
located in the PZ. In contrast, microvessel alterations and
neovascularity in prostate cancer cause increased tumor
vascularity with early enhancement and rapid washout of
contrast material from prostate cancer lesions [1]. Kawada
et al [11] showed early and prolonged-ring enhancement in all
cases of BCG-induced GP. In our case, the focal area of
capsular penetration and extraprostatic spread, in retrospect,
shows ring enhancement on the arterial, venous, and equi-
librium phases (Fig. 5), consistent with caseous necrosis and
small extraprostatic abscess.
Thus, multiparametric MRI appearances simulate prostate
cancer [11]. Based on clinical findings and initial in-
vestigations, patients often undergo prostate biopsy. In a bid
to reduce biopsy morbidity and prevent delays in treatment,Fig. 5 e DCE images obtained in arterial (A), venous (B), and equ
enhancement (arrows) at the site of focal capsular penetration.some centers have suggested proceeding directly to radical
prostatectomy in patients with high pretest probability of
prostate adenocarcinoma [12]; however, a similar policy in
this case would have resulted in overtreatment and poten-
tially increased patient morbidity.
Histologically, widespread nonspecific GP may also simu-
late carcinoma. Typically, nonspecific GP shows a prolifera-
tion of epithelioid histiocytes, along with variable numbers of
multinucleated giant cells, eosinophils, neutrophils, and
lymphocytes (Fig. 6). The epithelioid histiocytes may grow as
monomorphic sheets, obliterating normal glandular archi-
tecture, and suggesting high grade, that is, Gleason 5, carci-
noma [5,13]. Caseation is usually absent in nonspecific GP.
Diagnosis may be aided by recognition of the inflammatory
nature of cells, along with associated giant cells and fibrosis.
Challenging casesmay require immunohistochemistry for the
identification of epithelioid histiocyte CD68 expression. In
contrast, prostate adenocarcinoma expresses PSA, prostate-
specific acid phosphatase, and cytokeratins [13].
Infectious causes and postsurgery GP do not usually cause
problems in the differential diagnosis. Infectious GP isilibrium (C) phases, showing early and prolonged-ring
Fig. 6 e Pathology slide from transperineal biopsy core.
Nonspecific GP adjacent to prostatic acinus (3) with a
predominantpopulationofmixed inflammatory cell infiltrate
including epithelioid histiocytes (1) and giant cells (2).
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cells and caseation. Patients may have a clinical history of
systemic tuberculosis or recent BCG therapy for bladder
cancer [14]. Postbiopsy GP patients will have had a recent
biopsy or transurethral resection of the prostate; granulomas
will be distributed along the surgery and/or biopsy edge on
histology [15].
GP is a benign condition. Nonspecific GP resolves naturally
through scarring and often needs no further treatment [4].
However, any underlying urinary tract infection should be
treated with antibiotic therapy. Patients may continue to be
symptomatic during disease resolution and may require
supportive measures such as analgesics, in particular
nonsteroidal anti-inflammatory drugs [16]. Alpha-receptor
antagonists, such as tamsulosin, may help reduce bladder
outflow obstruction and improve voiding dysfunction that is
common with chronic prostatitis.Conclusions
GP is a benign inflammatory condition of the prostate which
may be confused clinically, radiologically, and pathologically
with prostate adenocarcinoma. Therefore, all patients with
suspicious prostate lesions on MRI require formal histopath-
ologic disease confirmation before proceeding to radical
treatment.r e f e r e n c e s
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